For adults with obesity and migraine, liraglutide reduces migraine burden, with reductions in mean monthly headache days.

Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...

A recent study suggests that liraglutide, a drug similar to Ozempic, may reduce migraine frequency in obese individuals with ...

The Delhi High Court has instructed India's drug regulator to address concerns about the approval process for drugs like ...

Subsequent hospitalization rates were lower among patients with type 2 diabetes who received liraglutide compared with glimepiride.

A common diabetes drug may be the next big thing for migraine relief. In a clinical study, obese patients with chronic ...

Liraglutide, a medication commonly used to treat diabetes, has shown promising results in reducing chronic migraine in ...

A new study finds that the diabetes drug liraglutide significantly reduced monthly migraine days in patients with obesity and ...

Oral DehydraTECH-liraglutide showed a pronounced reduction in adverse events (“AEs”) as compared to injected liraglutide (Saxenda (R)) Lexaria has now demonstrated, in distinct human clinical ...

A GLP-1 drug led to fewer days with headaches, a small pilot study of migraine sufferers shows. It may work by lowering pressure inside the head.

GLP-1 drug liraglutide could become a new treatment option for the estimated one in seven people worldwide who live with migraines ...

“Our findings show liraglutide may be effective for treating stubborn, high-frequency migraines in patients with obesity, and ...